Apollomics Inc.
No enriched coverage for $APLM in the last 7 days.
Apollomics Inc. (APLM) said CEO Hung-Wen Chen bought shares on Aug. 14, 2026, including 166,667 shares at $12 and 103,333 at $15 directly, plus 266,667 at $15 via King Regent Management. Total buys were about $7.55 million, raising direct holdings to 418,334 and indirect to 1,029,695. APLM shares rose to $23.55 Monday.
Investing.com reports U.S. insider trades disclosed Monday. Apollomics (APLM) saw CEO Hung-Wen Chen buy about $7.55M and CFO Peter Lin buy $400k. Cardinal Infrastructure (CDNL) had multiple buys totaling about $6.48M. Dyne (DYN), Butterfly Network (BFLY), Kinetik (KNTK), and PBF Energy (PBF) reported large sales.
After-hours gainers included Profusa (PFSA) after a 1-for-4 reverse split, with shares outstanding cut to about 605,726. INVO Fertility (IVF) rose after Q2 results: revenue about $2.2M (+17% YoY) and net income about $0.9M. Amylyx (AMLX) traded higher ahead of Phase 3 LUCIDITY topline results on Aug 18, 2026. Vogenx (VOGX) and others also gained.
Recent APLM coverage spans insider activity, market movers and financial news.
In the last 30 days, APLM insiders filed 5 SEC Form 4 transactions — 5 purchases ($8.3M) and no sales. The most active reporter was Chen Hung-Wen, Chief Executive Officer, with 3 filings.
Insider buying can support near-term sentiment, but it is not a fundamental catalyst like trial readouts or guidance.
Insider buying at a discount to the current ~$23.55 price can support near-term sentiment, but it is not a fundamental catalyst by itself.
A small capital raise can support liquidity expectations, but dilution risk can cap upside.
This is a disclosed insider open-market purchase, which can be read as incremental bullish sentiment, but it is not a fundamental catalyst by itself.
The filing is a disclosed insider buy, but it is not tied to new fundamentals or guidance in the text.
alphai scores every news story that mentions APLM with an AI model for sentiment and relevance, and aggregates insider trades from Apollomics Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Apollomics Inc. (APLM) said CEO Hung-Wen Chen bought shares on Aug. 14, 2026, including 166,667 shares at $12 and 103,333 at $15 directly, plus 266,667 at $15 via King Regent Management. Total buys were about $7.55 million, raising direct holdings to 418,334 and indirect to 1,029,695. APLM shares rose to $23.55 Monday.
3 min readInvesting.com reports U.S. insider trades disclosed Monday. Apollomics (APLM) saw CEO Hung-Wen Chen buy about $7.55M and CFO Peter Lin buy $400k. Cardinal Infrastructure (CDNL) had multiple buys totaling about $6.48M. Dyne (DYN), Butterfly Network (BFLY), Kinetik (KNTK), and PBF Energy (PBF) reported large sales.
7 min readAfter-hours gainers included Profusa (PFSA) after a 1-for-4 reverse split, with shares outstanding cut to about 605,726. INVO Fertility (IVF) rose after Q2 results: revenue about $2.2M (+17% YoY) and net income about $0.9M. Amylyx (AMLX) traded higher ahead of Phase 3 LUCIDITY topline results on Aug 18, 2026. Vogenx (VOGX) and others also gained.
7 min readChen Yi-Kuei (Chief Operating Officer) purchased 20,000 indirectly-held shares of Apollomics Inc. (APLM) at $15.00 ($0.30M total) on 2026-08-14.
2 min readLIN PETER KUAN-HOW (Chief Financial Officer) purchased 26,667 shares of Apollomics Inc. (APLM) at $15.00 ($0.40M total) on 2026-08-14.
1 min readChen Hung-Wen (Chief Executive Officer) purchased 266,667 indirectly-held shares of Apollomics Inc. (APLM) at $15.00 ($4.00M total) on 2026-08-14.
2 min readChen Hung-Wen (Chief Executive Officer) purchased 270,000 shares of Apollomics Inc. (APLM) at an average of $13.15 ($12.00–$15.00, $3.55M total) across 2 trades on 2026-08-14.
1 min readApollomics Inc. (APLM) said it entered definitive subscription agreements for a roughly $10 million private placement. It includes cash subscriptions for 533,334 Class A shares at $15.00 (about $8.0 million) and conversion of a $2 million unsecured convertible note into 166,667 shares at $12.00. Closing is expected around Aug. 14, 2026. APLM shares were $18.16 Tuesday.
4 min readBiotech stocks rose on multiple catalysts. CareDx (CDNA) jumped 35.6% after Medicare finalized an LCD covering its transplant molecular testing, effective Aug. 30, 2026. AtaiBeckley (ATAI) gained 33.4% on an Eli Lilly (LLY) acquisition deal up to $3.8B. Abbott (ABT) rose 10.7% after Q2 results and raised FY26 adjusted EPS outlook to $5.45-$5.60.
7 min readBiotech stocks rose Wednesday. Apollomics (APLM) jumped 22% after Nasdaq closed its MVLS compliance issue. Iovance (IOVA) gained 21% ahead of Q2 results; AVITA Medical (RCEL) rose 18% before Aug. 6 earnings; Annexon (ANNX) climbed 17% ahead of ARCHER II updates. Veradermics (MANE) gained 12% on Phase 2 hair-loss topline results.
7 min read